Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.1ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
AS.1ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
AS.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
AS.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
AS.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
AS.1SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
B.1.142ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.142ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.142ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
B.1.142ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
B.1.142ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
B.1.142ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.142ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.142ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
B.1.142ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.142SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.142SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
B.1.142SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.142EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.142ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.142EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.256NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.256NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.256ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
B.1.1.256ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
B.1.1.256ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.1.256SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
B.1.1.256SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
B.1.1.256SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
Q.7 (Alpha)ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
Q.7 (Alpha)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
Q.7 (Alpha)ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
Q.7 (Alpha)ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
Q.7 (Alpha)ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
Q.7 (Alpha)ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
Q.7 (Alpha)ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
Q.7 (Alpha)ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
Q.7 (Alpha)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
Q.7 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Q.7 (Alpha)SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
Q.7 (Alpha)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Q.7 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.7 (Alpha)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Q.7 (Alpha)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Q.7 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.7 (Alpha)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17351.3China
Q.7 (Alpha)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Q.7 (Alpha)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used